PHILADELPHIA--(BUSINESS WIRE)--Context Therapeutics, LLC, a clinical-stage biopharmaceutical company focused on hormonally-driven cancers, announced that Martin Lehr, Co-founder and CEO of Context Therapeutics, is a semifinalist for Ernst & Young's (EY) 2018 Entrepreneur of the Year for ...
more here
No comments:
Post a Comment